27550 Durability of response to abrocitinib in patients with moderate-to-severe atopic dermatitis (AD) after treatment discontinuation in a phase 2b trial
Saved in:
Published in | Journal of the American Academy of Dermatology Vol. 85; no. 3; p. AB151 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2021
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0190-9622 1097-6787 |
---|---|
DOI: | 10.1016/j.jaad.2021.06.619 |